ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1652

Lupus Research Action Network: Increasing Minority Clinical Trial Participation Through Peer Leaders

Melicent Miller1, Stephanie Slan1, Rosalind Ramsey-Goldman2, Rodlescia Sneed3, Candace Feldman4, Patrick Wildman1, Tori Justin5, Lydia Oberholtzer5 and Joy Buie6, 1Lupus Foundation of America, Washington, DC, 2Northwestern University, Chicago, IL, 3Wayne State University, Detroit, MI, 4Brigham and Women's Hospital, Boston, MA, 5Sharp Insight, LLC, Montgomery County, MD, 6Lupus Foundation of America, York, SC

Meeting: ACR Convergence 2023

Keywords: clinical trial, education, patient, Lupus nephritis, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Interprofessional Exemplary

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Black/African American people with lupus (PWL) experience greater disease prevalence and severity than White PWL. The need for more racial and ethnic diversity amongst lupus clinical trial (CT) participants is needed as there continues to be a high level of unmet medical need within this population. Lack of trust has been found to negatively influence Black/African American participation in CT that contributes to higher perceptions of bias and racism among this population. Peer-to-peer models such as CDC’s Popular Opinion Leader (POL) has been shown to be effective in building trust and confidence within the community while empowering PWL to take leadership roles in communicating the importance of diversifying CT participation.

Methods: The Lupus Conversations Program, an evidence-based curriculum based on the POL model, aims to improve the awareness of lupus CT, increase knowledge of the CT process as well as addressing barriers, facilitators, and mediators to CT participation such as structural racism in research among Black/African American PWL. This model was adapted and employed through virtual and in-person training sessions for Lupus Research Action Network (LRAN) members with goals of increasing knowledge, confidence, and intent to engage in peer-to-peer outreach opportunities to discuss the importance of participation in lupus CT among Black/African American PWL. A retrospective pre-post survey was developed to assess participant demographics and increases in CT knowledge and awareness of trials, self-efficacy, and confidence to share CT information with peers, and examine training satisfaction.

Results: LRAN members participated in one of two trainings in September 2022 (n=40) and April 2023 (n= 27). Almost all LRAN survey respondents identified as female. The average age of participants was 42 (n=63). Over two-thirds of the training participants identified as Black/African American. Almost a quarter identified as White, 12% as Hispanic, Latino or Spanish origin, 6% as Asian or Pacific Islander, and 2% as Native American. LRAN members resided in 12 states. Over 90% of LRAN members reported satisfaction with LRAN training content, facilitation, and engagement. Sixty percent reported an increased understanding of CT needs and barriers to enrollment among racial and ethnic minority PWL. Eight out of ten increased their understanding of CT and racism and increased their awareness of lupus CT and outreach markets. Nearly all participants increased their commitment to diversifying CT participation for PWL, confidence in connecting target population with lupus CT information and resources, and behavioral intention to engage their community through outreach to racial and ethnic minority PWL to connect them to information and resources related to lupus CT.

Conclusion: An adapted, community-based POL model can be used to increase awareness of and commitment to diversifying participation in lupus CT among Black/African American PWL. Further research is needed to determine the degree to which a peer-to-peer education module may reduce disparities in CT participation among Black/African American PWL. Existing level of CT knowledge must be considered when developing patient-centered content.

Supporting image 1

Race and Ethnicity of LRAN Training Participants

Supporting image 2

Changes in confidence, commitment, and behavioral intentions for diversifying minority participation in CT

Supporting image 3

Overall LRAN Training Performance Measures


Disclosures: M. Miller: None; S. Slan: None; R. Ramsey-Goldman: Ampel Solutions, 2, Calabetta, 2, Exagen, 2, Immunocor, 6; R. Sneed: None; C. Feldman: BMS Foundation, 5, Curio Bioscience, 12, My husband is one of the founders and will receive equity (but has not received anything to date)., OM1, Inc., 2, Pfizer, 5; P. Wildman: None; T. Justin: None; L. Oberholtzer: None; J. Buie: None.

To cite this abstract in AMA style:

Miller M, Slan S, Ramsey-Goldman R, Sneed R, Feldman C, Wildman P, Justin T, Oberholtzer L, Buie J. Lupus Research Action Network: Increasing Minority Clinical Trial Participation Through Peer Leaders [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/lupus-research-action-network-increasing-minority-clinical-trial-participation-through-peer-leaders/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-research-action-network-increasing-minority-clinical-trial-participation-through-peer-leaders/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology